The rapid advances in AI and smartphone technologies hold promise for many stakeholders in the healthcare system — providers, payers, pharmaceutical drugmakers and public health agencies — that need to understand what's happening with the patient in real time.
Addressing difficult-to-treat diseases and disorders, quickly, safely, and with little to no side effects is a positive boon to our overburdened health system.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
This post is sponsored by Sprint and is the fifth article in a 12-part series on mobilizing healthcare for improved communication. The iPhone is only seven years old, but it’s tough to remember life w ithout it. In the years since the iPhone’s 2007 release, the smartphone has become ubiquitous. Today, 58 percent of Americans […]